Human MCs were identified as a potential source of TNF shortly after the finding was reported for mouse MCs, 7 and evidence was presented that these cells also could contain preformed stores of the cytokine in their granules. 7 IL-4 was reported to be a potential product of mouse MC lines in 1987 8 and 3 groups subsequently reported the ability of various populations of in vitro-derived mouse mast cells or long term mouse MC lines to secrete IL-4 and several other cytokines in response to activation via the FcεRI 9-11 and the Burd et al. paper 11 also added a few chemokines to the growing list of cytokines which could be considered as potential products of mouse MCs.
As reviewed herein, the list of cytokines, chemokines, growth factors, and mitogens which now have been identified as MC products is very long (Figure 1 , Tables 1 & 2) . And while many of these were first identified, at the mRNA or protein level, in in vitro-derived mouse or human MCs, there is evidence that several of these can be considered to be at least potential products of native populations of mouse or human tissue MCs. However, while it can be relatively straightforward to generate evidence that MCs might represent a source of particular cytokines, chemokines, growth factors, and mitogens, it is much more difficult to determine the biological importance of MCs as sources of such molecules, particularly in settings where multiple different immune cells and structural cells represent alternative potential sources of the same products.
In this review, we describe the evidence that MCs represent potential sources of cytokines (including chemokines), growth factors, and mitogens, and mention the potential or proven roles of these products, eg, as "pro-inflammatory" or "regulatory" cytokines; or influencing MC development, survival and/or proliferation; or functioning as mitogens or chemokines. As noted in Tables 1 & 2 , much of the evidence that MCs can secrete such products is derived from studies of in vitro-derived mouse or human MCs, or MCs purified from mouse body fluids or mouse or human tissues. Importantly, we note that in many instances it has not yet been confirmed whether, and under which circumstances, MCs can secrete such products in vivo. Some of the many considerations to be kept in mind when evaluating the evidence that MCs represent potentially important sources of particular cytokines, chemokines, growth factors, or mitogens are listed in Table 3 .
Immunohistochemistry (IHC) has often been used to identify cytokines and growth factors in MCs in tissue sections, and the identification of such immunoreactivity is of interest (eg, it can be taken to represent one line of evidence that some of the products so identified can be stored in or associated with the MC's cytoplasmic granules).
However, this approach by itself cannot determine the importance of
MCs as a source of these molecules, which typically also can be produced by many other cell types. Moreover, in many of these "non-MC" sources of these products, the cytokines or growth factors may be rapidly secreted and therefore provide little signal for detection of cellassociated product by IHC.
Accordingly, when it is available, we have commented on more direct lines of evidence that MC production of particular cytokines, chemokines, growth factors, or mitogens has relevance for understanding the roles of MCs in vivo. We think that the reader will appreciate that while we are still far from understanding the importance of most of these products in contributing to critical roles of MCs in physiological or pathological processes, we now have many interesting possibilities to assess, as well as increasingly powerful tools to provide more definitive answers to these questions.
| MAST CELL-DERIVED CYTOKINES, GROWTH FACTORS, AND MITOGENS

| TNF (tumor necrosis factor)
| History
TNF (tumor necrosis factor/cachectin) was first described by Carswell et al. in 1975 12 as a factor found in the serum of bacillus CalmetteGuerin (BCG)-infected mice that induces tumor necrosis. This and several other studies showed that TNF can be released from macrophages upon endotoxin stimulation. [13] [14] [15] Later, evidence was reported that some MC lines (C57.1, 2D4, t1C9, AI, RBL-2H3, PT18), 4, 16 IL-3-maintained bone marrow-derived cells (which were reported to be "natural cytotoxic cells", but in retrospect almost certainly were MCs 17 ), IL-3-derived mouse bone marrow-derived MCs (BMCMCs) and purified rat or mouse PMCs, 4 rat connective type MCs, 18 and F I G U R E 1 Highly simplified overview of the diverse stimuli and potential consequences of mast cell activation and secretion of cytokines, chemokines, and growth factors. Mast cells (MCs) can be activated through various receptors when they are exposed to the corresponding ligands (eg, in pink ovals). This can induce MC activation (red arrows), inhibition (blue dotted lines), or migration (purple open arrows), influence MC development/proliferation/survival (green patterned arrows), and/or induce MCs to secrete many cytokines, chemokines, and growth factors (black arrows and related boxes). Gray arrows depict secretion of products from cells other than MCs. Depending on the type of stimulus/stimuli, as well as the type/phenotype of the MCs, such activated MCs also may secrete many other stored and/or newly synthesized mediators (not shown). In adaptive immune responses (eg, elicited by parasites, animal venoms, or allergens), MCs can be activated when IgE bound to surface FcεRI receptors is crosslinked by bi-or multivalent antigens, or when immune complexes (IgG-ICs) bind to FcγRs. In some settings, for example, in mouse BMCMCs, co-ligation of FcεRI with inhibitory FcγRIIb receptors can downregulate MC activation. 349, 350 FcγRI is a high-affinity receptor induced in human MCs by IFNγ stimulation in vitro 231 or in the IFNγ enriched environment of skin MCs in the setting of psoriasis. 351 However, this FcγRI expression is observed in humans not in mice. Upon antibody/antigen-mediated stimulation, MCs can synthesize and secrete a panel of factors as indicated in the black boxes. In turn, those factors can influence other immune and non-immune (structural) cells and contribute to pathogenesis of various types of allergic reactions and perhaps autoimmune disorders, such as some forms of arthritis, as well as to host defense against venoms or parasites. Many of the immune and structural cells depicted are comprised of functionally distinct subtypes (eg, T cells, DCs, macrophages, fibroblasts, nerves) and the effects of particular MC products on such cells may vary importantly depending on the target cell subtype (not shown). In some settings, such MC-derived products also may contribute to tissue repair and remodeling, both through effects on structural cells and by regulating aspects of the inflammatory/immune response. Antibody/antigenmediated stimulation also can induce MCs to secrete preformed mediators such as histamine, serotonin (in rodents, primarily), proteoglycans, and proteases (not shown), as well as certain cytokines and growth factors which can be granule-associated (black boxes and the purple granules underneath), as well as many lipid mediators including cysteinyl leukotrienes and certain prostaglandins (not shown). IL-33, which is produced by endothelial/epithelial cells in sites of tissue damage, can stimulate MCs to secrete many factors (indicated in the black boxes) with diverse potential effects on other immune and non-immune cells that can contribute to the pathogenesis of allergies and to host defense. Products of pathogens such as LPS (lipopolysaccharide) and PGN (peptidoglycan), poly (I:C), and certain viruses can directly activate MCs through TLRs (Toll-like receptors), resulting in the secretion of a variety of factors (as indicated in black boxes); depending on the setting, this could contribute to host defense and/or disease (eg, there is a well-established clinical association between certain viral infections and exacerbations of asthma). During Th2 cell-associated immune responses, IL-4 or IL-9 from T cells or from immature cells in the MC lineage can activate MCs and promote their development/proliferation. IFNγ can deliver positive or negative signals to MCs, probably depending on species of animal, MC subpopulation, and setting (such as a disease or a particular beneficial host response). MCs can migrate in response to certain chemokines, but MCs also can be activated by chemokines. IL-3 and SCF (stem cell factor) are representatives of factors which support MC development, proliferation, and/or survival (others include, depending on the MCs, IL-4, IL-6, IL-9, and NGF). IL-3 can have similar effects on basophils. NGF (nerve growth factor), VEGF (vascular endothelial growth factor), FGFs (fibroblast growth factors), and TGF-β1 (transforming growth factor type-β) can contribute to the development of fibrosis or angiogenesis, and there is some evidence indicating that these factors, like TNF (tumor necrosis factor), can be constitutively stored in the granules of some MCs. These factors also can influence MCs (as indicated with arrows). Substance P is a product of certain neurons that can potently activate some types of MCs, which in turn can secrete preformed mediators that may include granule-associated cytokines (as indicated in the black boxes). Bidirectional interactions between certain nerve cells and MCs have been studied extensively, and there is considerable interest in the potential importance of such nerve-MC interactions in health and disease. Finally, it should be kept in mind that proteases released from activated MCs can degrade TNF,  61 IL-1β,  352 IL-18,  353 IL-33,  209,211 SCF,  354 CCL5 and CCL11, 355 CCL26, 356 and likely other factors shown in the figure, and this may represent an important mechanism by which MCs can control the intensity and duration of the biological effects of such factors. Please see Tables 1 and 2 for additional information about how variation in MC subtype may influence the extent to which these cells can produce and/or respond to the factors shown in the figure and in vitro-derived mouse MCs that TNF travels from the endoplasmic reticulum (ER) to the cytoplasmic granules at least in part through N-linked glycosylation of TNF and via a mannose-6-phosphate receptor (MPR)-dependent pathway (RBL-2H3). 31 By contrast, human MCs (LAD2 MCs and the human MC leukemia cell line, HMC-1) appear to employ a different mechanism, which does not involve glycosylation of the TNF and therefore is carbohydrate independent, and that involves a pathway by which the newly formed TNF is transiently exposed to the extracellular space and then is followed by endocytosis. 
| Preformed TNF
| Roles of MC-derived TNF
In principle, MC-derived TNF could contribute to any biological response that is influenced by that cytokine. However, attention has focused mainly on the role of MC-derived TNF in various inflammatory
responses. An early idea was that the cytotoxicity mediated by MCderived TNF might play a role in tumor regression. However, while it has long been known (since Ehrlich's time 1 ) that numbers of MCs are increased in various types of tumors (reviewed in 33 ), the roles of MCs in such settings, let alone MC-derived TNF, are largely yet to be determined. [33] [34] [35] MCs have the potential to secrete a wide spectrum of cytokines, growth factors, and other mediators that can have positive or negative effects on tumors and their relationship to the microenvironment (eg, see Table 1 ), and TNF is just one among many such products.
By contrast, several lines of evidence indicate that MC-derived TNF can contribute to leukocyte recruitment at sites of inflammation.
Studies employing a neutralizing antibody to TNF indicated that this cytokine can promote leukocyte recruitment into sites of IgE-and MC-dependent passive cutaneous anaphylaxis in mice. 36, 37 In certain delayed hypersensitivity responses elicited in the skin of mice, there is evidence that MC-derived TNF, as well as the MC-derived chemokine, macrophage inflammatory protein 2 (MIP-2), can contribute to neutrophil recruitment. 38 In antigen-induced neutrophil infiltration into the airways of ovalbumin (OVA)-specific TCR-expressing OTII mice, there was evidence that MC-derived TNF can contribute to neutrophil recruitment in a Th17-cell-dependent manner. 39 In mouse models of hapten-induced contact hypersensitivity, 2 groups provided evidence that MC-derived TNF can contribute to the migration of skin dendritic cells 40, 41 and airway dendritic cells 40 to the draining lymph nodes. Those findings, which indicated that MCderived TNF can modulate DC function and thus adaptive immunity, were generated using adoptive transfer approaches to compare the tissues may alter aspects of MC phenotype and function, including their ability to make or respond to cytokines, chemokines, and growth factors *All of these factors may influence the MC's ability to produce cytokines, chemokines and growth factors, and/or to produce and secrete proteases and other factors that can influence the structure and bioactivity of these molecules. BMCMCs: Mouse bone marrow-derived cultured mast cells (these are reported by many groups as "BMMCs"-referring to "bone marrow-derived mast cells", but we prefer BMCMCs to refer to such cells as this is more specific and emphasizes that the cells have been derived in vitro. CBMCs: Human umbilical cord blood-derived mast cells. PBMCs: Human peripheral blood-derived mast cells. PMCs: Peritoneal mast cells (from mice or rats, as noted).
In the Product column: Detected product was the protein unless "mRNA" is listed, which indicates that the mRNA for that product was identified, but not yet the protein.
In the References column: Papers listed include first reports and/or those with key data. (also known as tumor necrosis factor receptor superfamily, member 4
[TNFRSF4], and CD134). 46 These studies highlight the potentially diverse and non-mutually exclusive mechanisms by which MC-derived TNF can influence adaptive immunity, and we think it likely that additional mechanisms remain to be discovered.
MC-derived TNF can also influence non-immune cells. In a mouse model of oxazolone-induced contact hypersensitivity, there is evidence that MC-derived TNF can contribute to nerve elongation, perhaps via induction of nerve growth factor (NGF) production by keratinocytes. 47 Close association between MCs and nerves is often observed in inflammatory skin lesions, [48] [49] [50] and further studies are needed to elucidate the molecular mechanisms which underlie functional associations between MCs, MC-derived TNF (and other MCderived mediators) and nerves in this and other settings.
In mice, there is evidence that, after MCs are activated with IgE and antigen in vivo or in vitro, MC-derived TNF and MC-derived TGF-β1 can increase type-I collagen production in fibroblasts. 51 Taken together, these findings support the hypothesis that, depending on the circumstances (including mouse strain background, the nature of the mutation resulting in the MC deficiency, and type and severity of the infection), MCs can have either no detectable effect or even opposite effects on survival during bacterial infections.
As discussed in detail elsewhere, [62] [63] [64] a caveat about these findings is that much of the work reviewed above was performed using mice that were MC-deficient because of mutations affecting c-kit structure or expression, and such mice have multiple phenotypic abnormalities in addition to their profound MC deficiency.
In summary, current evidence indicates that MC-derived TNF can contribute to the initiation and amplification of inflammation, particularly in its early stages, during certain innate and adaptive immune responses, and that TNF (particularly that associated with exteriorized MC cytoplasmic granules) also may contribute to the development of certain adaptive immune responses. However, MC-derived TNF may be a 2-edged sword, which in some settings contributes more substantially to pathology than to host defense.
| IL-1β
IL-1β is an important pro-inflammatory cytokine that can be involved in various inflammatory diseases. 
| IL-2
IL-2 can have effects on many immune cells, and is especially important for Treg cell development and homeostasis. 71 The critical 
| IL-3
IL-3 has been well characterized as a cytokine which supports MC and basophil differentiation, growth, survival, and expansion. [75] [76] [77] [78] [79] Later, Dudeck et al, 159 working with strains of MC-deficient mice that had normal c-kit, (ie, "Kit-independent MC-deficient mice") reported that, in their models of CHS, MCs promoted the intensity of the reactions rather than having a suppressive effect. The latter findings were in accord with prior work indicating that, in some settings, 
| IL-10
COLOUR
were studying CHS responses of different severity and duration. This is important, in that Gimenez-Rivera et al 163 recently reported additional evidence, derived from studies using a different model of CHS tested in both "Kit-dependent" and "Kit-independent" MC-deficient 164 In part to address the "controversy" regarding the different conclusions of the studies by Grimbaldeston et al 157 and Dudeck et al, 159 Reber et al 165 To assess the potential role of MC-derived IL-10 in this model of severe CHS, Reber et al 165 
| IL-11
IL-11 is multifunctional cytokine that belongs to IL-6 cytokine family.
Indeed, by structure, IL-11 is the cytokine that is most closely related to IL-6 and they share gp130 as a component of their receptors (reviewed in [172] [173] [174] . Various functions are also shared among IL-6 cytokine family members, and IL-11, which can promote thrombopoiesis, is used to prevent the development of chemotherapy-induced thrombocytopenia. 172 ,174,175 IL-11 can be produced by many kinds of cells including leukocytes, epithelial cells, and fibroblasts, and is thought to be involved in the pathogenesis of asthma, airway hyperresponsiveness, and lung inflammation. [176] [177] [178] One report indicated that human umbilical cord blood-derived MCs can produce IL-11 in response to an IgE-mediated stimulus. 179 However, the importance of MCs as a potential source of IL-11 remains to be determined.
| IL-12
IL-12 is important for the induction of Th1 responses and for stimulating IFNγ production from Th1 cells and NK cells. PMA (phorbol 12-myristate 13-acetate) and ionomycin, 188, 190 LPS or PGN, 57, 58, 107 or IL-33. 73, 125, 191, 192 Human MCs produce IL-13 upon IL-1β stimulation 190 and mouse MC IL-13 production by IgE/Ag stimulation can be enhanced in the presence of IL-1β. 135 SCF can induce IL-13 production in mouse MCs. 193 IL-13 is also produced by many other cell types including T cells, basophils, eosinophils, and epithelial cells. A series of studies now suggest that ILC2-derived IL-13 plays a critical role in host defense to infections with certain parasites and in the pathogenesis of type-2 immune responses. 185, 194, 195 Further research is needed to understand the importance of MC production of IL-13, especially in those in settings in which many other cell types also elaborate this product. T A B L E 4 New approaches for analyzing MC production of cytokines, chemokines, and growth factors
| IL-13
| IL-16
• Constitutive or inducible genetic ablation or reduction, in all MCs or in particular subpopulations of MCs, of individual or multiple cytokines, chemokines, or growth factors (or of receptors for such products, or of other MC products, such as proteases, which may regulate levels and activity of cytokines, chemokines, or growth factors) 42, 159, 165, 384 • Real-time simultaneous imaging of MC activation and gene expression in normal or diseased tissues in vivo 165 • Single cell analysis of MC mRNA, products, and metabolites (either ex vivo or in situ) • Advances in approaches to generate and analyze mice of diverse genetic backgrounds, which can be used to assess the extent to which genetic background can influence the importance of MC production of particular products in specific settings [385] [386] [387] • Advances in the ability to use more definitive experimental approaches to analyze the effects of microbiomes and their metabolites, as well as exposure to UV light, environmental toxins and other environmental factors, on the capacity of MCs to produce, regulate or respond to cytokines, chemokines, and growth factors
| EGF (epidermal growth factor)
Epidermal growth factors stimulate proliferation and differentiation of various cells including fibroblasts, endothelial cells, and epithelial cells. 213 MC-derived FGF2 is considered to be a potential pro-angiogeneic factor. 216 Immunoreactivity for FGF2 has been detected by IHC in MCs in human fibrotic lung tissue, rheumatoid synovia, and skin hemangiomas, 217 in human thyroid MCs, 214 and in rat PMCc, 34 and MCs containing FGF2 in a granule-associated form with heparan sulfate were detected in human skin using a binding assay with biotinylated FGF2. 218 Secretion of FGF2 has been reported for human dermal MCs and HMC-1 cells. 215 There is a report that IL-17A can increase the secretion of FGF2 from human CD133 + progenitor-derived cultured
MCs. 219 In addition to FGF2, other factors with mitogenic activity on fibroblasts, including FGF7 and FGF10, can also be detected in human dermal MCs. 215 The importance of FGF2 production by MCs in vivo is not yet understood. However, Wroblewski et al 220 have suggested that one reason VEGF-targeted therapy becomes less effective is that MCs reactivate angiogenesis in part by secreting FGF2.
| GM-CSF
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine which facilitates the development of granulocytes and macrophage from precursors in bone marrow. 221 MCs can produce GM-CSF upon IgE-mediated stimulation, 10, 11, 109, 222 
| PDGF (platelet-derived growth factor)
PDGF is an important mitogen that can contribute to angiogenesis by facilitating the growth of blood vessels. [263] [264] [265] 
| TGF-β1
Transforming growth factor type-β (TGF-β) has many biological activities, and is thought to be a particularly important contributor to fibrosis, angiogenesis, and tissue repair. In addition, TGF-β can influence T cells, including Th17 and Treg cells (reviewed in [281] [282] [283] [284] [285] ), as well MCs derived from human skin. 293 Co-exposure to TGF-β1 can also inhibit the IL-33-induced release of multiple mediators from mouse
BMCMCs including TNF, MCP-1, IL-6, IL-13, and MIP-1α. 192 There is evidence that TGF-β1 can have autocrine effects which inhibit the proliferation of mouse BMCMCs 294 and cultured mouse PMCs. 294, 295 One mechanism by which TGF-β1 may suppress the IgE-dependent activation of some MC populations is its ability to reduce levels of expression of FcεRI on the MC surface. 296 In vivo administration of TGF-β1 can inhibit immediate and delayed type hypersensitivity reactions, although this might reflect indirect effects rather than actions specifically on MCs. 297 On the other hand, there are reports that TGF-β1 either can enhance mediator production in certain types of MCs in vitro 298, 299 and in vivo 300 or have no effect in BMCMCs in vitro. 294 
| VEGF (vascular endothelial growth factor)/ VPF (vascular permeability factor)
Angiogenesis is critically important in normal development and tissue homeostasis and repair, and can contribute to diverse forms of pathology, eg, tumor development and metastasis, psoriasis, rheumatoid arthritis, and wet macular degeneration. 308, 309 Observational studies have implicated MCs in angiogenesis in various settings and one of the most important MC products which may contribute to such roles is thought to be VEGF. 216 The molecule now called VEGF was initially discovered as a component of a guinea pig tumor ascites that can markedly enhance cutaneous vascular permeability in vivo, the bioactivity which was the basis of its initial name, vascular permeability factor (VPF). [310] [311] [312] [313] VPF later was found to be identical to VEGF, which was cloned and characterized in 1989. 314 The initially described VPF/VEGF, now called VEGF-A, is one of 5 members of the VEGF family in mammals that also includes placental growth factor (PGF), VEGF-B, VEGF-C, and VEGF-D. 315, 316 VEGF-A is a pro-angiogenetic factor which can enhance the angiogenesis process by promoting endothelial cell proliferation and migration, and, as its alternative name (VPF) indicates, VEGF-A also can potently enhance vascular permeability, with a molar potency roughly 1000 times that of histamine. [311] [312] [313] Many normal and neoplastic cell types can secrete VEGF, and 2
groups provided evidence that MCs should be added to that list. 317, 318 Moreover, there is evidence that MCs can constitutively contain VEGF as a preformed, heparin-binding factor 34, 317, 318 and can secrete this protein after stimulation by diverse triggers, including IgE and antigen (this was the first evidence that secretion of VEGF could be induced in an antigen-specific way in any cell type), PMA, A23187, or SCF suggesting a mechanism by which VEGF can have autocrine or paracrine effects on this lineage.
Given the large number of other cell types that also can produce VEGF, it may be difficult to identify settings in which MCs represent important or non-redundant sources of this cytokine. IgE-associated disorders represent one potential setting of this kind, in that relatively few cells other than MCs express the FcεRI, and it has been reported that VEGF immunoreactive MCs are increased in the airways of asthmatic patients compared to controls. [327] [328] [329] There are also several reports that MCs can be immunoreactive for VEGF in certain tumors including laryngeal squamous cell carcinoma, 330 malignant melanoma, 331 and non-Hodgkin lymphoma, 332 suggesting their possible involvement of MC-derived VEGF in tumorassociated angiogenesis. Evidence has been reported based on tests of several tumor models, using both Kit-dependent and Kit-independent MC-deficient mice, that MCs can contribute to tumor-related angiogenesis and other features of tumor progression. [333] [334] [335] MCs are increased in the areas of thyroid tissue regeneration in patients with subacute thyroiditis, and such MCs can exhibit immunoreactivity for VEGF, bFGF, PDGF, TGF-β1, and EGF. 214 In mice, several lines of evidence indicate that low-dose irradiation can promote tissue revascularization at least in part through MC production of VEGF. 336 However, this point needs to be investigated further, ideally by employing mice in which VEGF production can be selectively ablated in MCs.
| MAST CELL-DERIVED CHEMOKINES
Chemokines are cytokines which have chemotactic activities on various immune cells. [337] [338] [339] Chemokines play important roles in the development and homeostasis of the immune system and in the pathogenesis of inflammatory responses, including those associated with diverse disorders including allergic and autoimmune diseases, infections, and cancer. 338, [340] [341] [342] Beyond inducing chemotaxis, chemokines can also activate immune cells, including MCs, and play a critical role during HIV infection. 343 Therefore, chemokines are considered potential therapeutic targets in many diseases. [344] [345] [346] The first identification of MCs (in this case in vitro-derived mouse MCs and mouse MC lines) as a potential source of certain chemokines, specifically CCL1, CCL2, CCL3, and CCL4 mRNA, was in 1989.
11
Since then, various populations of mouse or human MCs, most often representing in vitro-derived MCs, 347 have been identified as potential sources of a now very long list of these molecules (Table 2) . Given:
(1) the vast number of biological responses in which chemokines are involved, (2) the large number of chemokines which MCs have at least the potential to produce, (3) the long list of stimuli (including IgE in the absence of known specific antigen 348 ) which can elicit chemokine production by MCs (Table 2) , in some cases without inducing substantial MC degranulation, and (4) the large number of other cell types which also represent a potential source of these mediators, it will be challenging to attempt to identify situations in which MCs represent important non-redundant sources of these molecules.
In 
| CONCLUSION
The long and growing list of cytokines, chemokines, and growth fac- Different MC populations also will vary in the extent to which they can produce and release mediators, such as their granule-stored proteases, which have the capacity to biochemically activate and/or degrade, or otherwise regulate levels of, cytokines, chemokines, or growth factors of MC or non-MC origin.
In light of these considerations, defining the actual roles of MCderived cytokines, chemokines, and growth factors in health and disease will require the application of more definitive tools than those used in the past to identify MCs as potential sources of these products. The good news is that a large number of new approaches for analyzing the importance of MCs as sources of such products already have been described (Table 4) . We anticipate that the thoughtful application of such new methods will enable us to identify many settings in which the production of particular cytokines and growth factors, by particular MC populations, makes a real difference in the initiation, amplification, or regulation of biological responses that contribute importantly to the maintenance of health or to features of disease. Such work also may help to identify new therapeutic targets in at least some of the disorders in which MCs play an important role.
